Across our channels, we regularly publish and engage in discussions about industry trends, changing regulations, and emerging technologies in clinical trials. This page hosts a selection of key articles and news.
According to The Economist, as much as 1 in 50 research papers includes results which are unreliable because of fabrication, plagiarism, or serious errors.
Triall will host a digital presentation at BIO-Europe titled "Unpacking EMA guidance on decentralised trials: implications for conventional and emerging technologies".
Triall CEO Hadil Es-Sbai authored an article for Applied Clinical Trials magazine, one of the leading industry journals for clinical research professionals.
Despite policy efforts to improve patient diversity in clinical research, under-representation of women, older adults, and racial & ethnical minorities remains a persistent problem.
In this article we take a closer look at decentralised clinical trials, the concept of decentralisation, and the impact of existing and emerging technology on clinical operations.
Blockchain offers great potential for safeguarding the integrity of clinical trial data and processes, but how does this work?
On Tuesday November 8th, our Chief Medical Officer will host a presentation titled “True Decentralisation of Clinical Trials: Demonstrating the Real Implications of Blockchain and Self-Sovereign Identity”.
Two clinical trial coordinators have been sentenced to prison after data falsifications scheme.
On November 7th, Triall will host a live webinar on emerging technologies in clinical trials together with its partner Crucial Data Solutions.
Triall is now a member of the Mayo Clinic Innovation Exchange, a platform that unites entrepreneurs, startups, and Mayo Clinic experts to bring breakthrough innovations to market.
Triall featured in Forbes Magazine with a spotlight article on our platform and blockchain-enabled vision for clinical research.
The Triall Newsletter provides a concise overview of product innovation updates, upcoming events, and anything else Triall-related.